HURA (TuHURA Biosciences) Debt-to-Asset : 0.29 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HURA TuHURA Biosciences Inc HURA
11 GF Score
Price $2.05
View Full Analysis

What is TuHURA Biosciences Debt-to-Asset?

TuHURA Biosciences HURA +0.99% 11 Debt-to-Asset is 0.29 as of Jun. 2026. GuruFocus rates HURA with a GF Score™ of 11/100.

TuHURA Biosciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $5.39 Mil. TuHURA Biosciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $3.79 Mil. TuHURA Biosciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was $31.75 Mil. TuHURA Biosciences's debt to asset for the quarter that ended in Jun. 2026 was 0.29.

TuHURA Biosciences  (NAS:HURA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

TuHURA Biosciences Debt-to-Asset Related Terms

TuHURA Biosciences Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences Debt-to-Asset Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
0.10 0.01 0.54 0.01 0.03

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.03 0.02 0.29

HURA vs INO, VTVT, CNTB: Debt-to-Asset Comparison

For the Biotechnology subindustry, TuHURA Biosciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Debt-to-Asset falls into.


HURA
11GF Score
TuHURA Biosciences Inc HURA
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

TuHURA Biosciences's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.396 + 0.304) / 27.353
=0.03

TuHURA Biosciences's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(5.387 + 3.793) / 31.746
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.29 mean?
TuHURA Biosciences (HURA) has a Debt-to-Asset of 0.29 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on TuHURA Biosciences and its competitors.
Is TuHURA Biosciences' Debt-to-Asset too high?
TuHURA Biosciences' current Debt-to-Asset is 0.29. Overall, TuHURA Biosciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Debt-to-Asset compare to INO and VTVT?
TuHURA Biosciences' Debt-to-Asset of 0.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on TuHURA Biosciences and its competitors. TuHURA Biosciences's current Debt-to-Asset is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current Debt-to-Asset of 0.29. The current Debt-to-Asset is 0.29. TuHURA Biosciences' overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current Debt-to-Asset is 0.29 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
11GF Score

Get the complete analysis for HURA

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.05
Price